Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Collinge

Showing results (71-80 of 295) with videos related to

Pageof 30
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|July 16, 2022
Prevalence and Treatments of Movement Disorders in Prion Diseases: A Longitudinal Cohort StudyDanielle Sequeira, Akin Nihat, Tzehow Mok, et al.
ACS Nano|February 21, 2023
Direct Observation of Competing Prion Protein Fibril Populations with Distinct Structures and KineticsYuanzi Sun, Kezia Jack, Tiziana Ercolani, et al.
The Lancet. Neurology|July 10, 2003
A 38-year-old man with a 9 month history of neurological and cognitive impairmentJohn Collinge, Sebastian Brandner, Angus Kennedy, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 18, 2008
Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion diseaseMelanie D White, Michael Farmer, Ilaria Mirabile, et al.
The Journal of General Virology|November 19, 2010
A standardized comparison of commercially available prion decontamination reagents using the Standard Steel-Binding AssayJulie Ann Edgeworth, Anita Sicilia, Jackie Linehan, et al.
Scientific Reports|September 5, 2020
Association of TDP-43 proteinopathy, cerebral amyloid angiopathy, and Lewy bodies with cognitive impairment in individuals with or without Alzheimer's disease neuropathologyDavid X Thomas, Sumali Bajaj, Kevin McRae-McKee, et al.
Biochemistry|January 3, 2007
Inhibition of proteinase K activity by copper(II) ionsLisa A Stone, Graham S Jackson, John Collinge, et al.
Transfusion|June 22, 2010
A highly sensitive immunoassay for the detection of prion-infected material in whole human blood without the use of proteinase KM Howard Tattum, Samantha Jones, Suvankar Pal, et al.
The Biochemical Journal|January 31, 2006
Removal of the glycosylphosphatidylinositol anchor from PrP(Sc) by cathepsin D does not reduce prion infectivityPatrick A Lewis, Francesca Properzi, Kanella Prodromidou, et al.
Neurogenetics|December 17, 2002
Identification of genetic loci affecting mouse-adapted bovine spongiform encephalopathy incubation time in miceSarah E Lloyd, James B Uphill, Paul V Targonski, et al.
Pageof 30

Showing results (71-80 of 295) with videos related to

Sort By:
Pageof 30
Movement Disorders : Official Journal of the Movement Disorder Society|July 16, 2022
Prevalence and Treatments of Movement Disorders in Prion Diseases: A Longitudinal Cohort StudyDanielle Sequeira, Akin Nihat, Tzehow Mok, et al.
ACS Nano|February 21, 2023
Direct Observation of Competing Prion Protein Fibril Populations with Distinct Structures and KineticsYuanzi Sun, Kezia Jack, Tiziana Ercolani, et al.
The Lancet. Neurology|July 10, 2003
A 38-year-old man with a 9 month history of neurological and cognitive impairmentJohn Collinge, Sebastian Brandner, Angus Kennedy, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 18, 2008
Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion diseaseMelanie D White, Michael Farmer, Ilaria Mirabile, et al.
The Journal of General Virology|November 19, 2010
A standardized comparison of commercially available prion decontamination reagents using the Standard Steel-Binding AssayJulie Ann Edgeworth, Anita Sicilia, Jackie Linehan, et al.
Scientific Reports|September 5, 2020
Association of TDP-43 proteinopathy, cerebral amyloid angiopathy, and Lewy bodies with cognitive impairment in individuals with or without Alzheimer's disease neuropathologyDavid X Thomas, Sumali Bajaj, Kevin McRae-McKee, et al.
Biochemistry|January 3, 2007
Inhibition of proteinase K activity by copper(II) ionsLisa A Stone, Graham S Jackson, John Collinge, et al.
Transfusion|June 22, 2010
A highly sensitive immunoassay for the detection of prion-infected material in whole human blood without the use of proteinase KM Howard Tattum, Samantha Jones, Suvankar Pal, et al.
The Biochemical Journal|January 31, 2006
Removal of the glycosylphosphatidylinositol anchor from PrP(Sc) by cathepsin D does not reduce prion infectivityPatrick A Lewis, Francesca Properzi, Kanella Prodromidou, et al.
Neurogenetics|December 17, 2002
Identification of genetic loci affecting mouse-adapted bovine spongiform encephalopathy incubation time in miceSarah E Lloyd, James B Uphill, Paul V Targonski, et al.
Pageof 30